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INTRODUCTION
Stimulants are a class of psychoactive substances that ex-
cite the nervous system through complex interactions with
monoamine transporters and neurotransmitters1. Cocaine
and amphetamines are the most commonly abused stimu-
lants, with an annual prevalence of 0.38% and 1.20% respec-
tively in those aged 15-64 years2. Stimulant use disorders are
characterized by the sustained use of these substances lead-
ing to substantial impairment and distress3. Common symp-
toms include craving for stimulants, failure to control use,
continued use despite interference with major obligations or
SUMMARY. Stimulant use disorders are highly prevalent with a large burden of disease. Most clinical guidelines recommend psychosocial in-
terventions, but there are no clear hierarchies or indications. Moreover, these interventions have been reported unevenly in the literature.
Identifying the most suitable treatment for each patient therefore represents a major challenge. In this review, we describe all psychosocial
interventions for stimulant use disorders investigated in randomized controlled trials – including contingency management, cognitive behav-
ioral interventions, community reinforcement approach, 12-step program, meditation-based interventions and physical exercise, supportive
expressive psychodynamic therapy, interpersonal psychotherapy, family therapy, motivational interviewing, drug counseling –, and we syn-
thesize the main findings of these studies. Similarities and differences between treatments are highlighted, suggesting that distinct psychoso-
cial interventions can be relevant for certain patients’ groups but not for others. Conversely, several interventions can be equally effective in
similar clinical contexts, suggesting that a shared element such as therapeutic alliance is key. Finally, combined approaches emerge as a viable
option for people with complex needs. Future studies will need to benchmark psychosocial interventions in stimulant use disorders and as-
certain markers of response with a view to individualized treatment.
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RIASSUNTO. I disturbi da uso di stimolanti sono altamente prevalenti e hanno gravi ripercussioni nei pazienti a livello medico, psicologico
e sociale. La maggior parte delle linee-guida cliniche raccomanda l’uso di interventi psicosociali per il trattamento, ma le indicazioni sono ge-
neriche e non si riferiscono a quali interventi psicosociali si debbano preferire. Inoltre, gli interventi sono stati riportati in modo non uniforme
in letteratura. Identificare il trattamento più adatto da offrire per un singolo paziente rappresenta una grande sfida. In questa revisione sis-
tematica, descriviamo tutti gli interventi psicosociali che sono stati studiati in studi clinici randomizzati per i disturbi da uso di psicostimolanti
e sintetizziamo i principali risultati di questi studi. Evidenziamo anche le somiglianze e le differenze tra i trattamenti, suggerendo che distin-
ti interventi psicosociali possono essere rilevanti per alcuni gruppi di pazienti ma non per altri. Al contrario, diversi interventi possono essere
ugualmente efficaci in contesti clinici simili. Infine, gli approcci combinati emergono come un’opzione praticabile, soprattutto in caso di dia-
gnosi doppia. Gli studi futuri dovranno valutare i marcatori di risposta in vista di un trattamento individualizzato.
PAROLE CHIAVE: disturbi da uso di psicostimolanti, interventi psicosociali, cocaina, amfetamina, revisione sistematica. 
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social functioning, use of greater amount over time, develop-
ment of tolerance, spending a great deal of time to obtain
and use stimulants, and withdrawal symptoms that occur af-
ter stopping or reducing use. These patients are at increased
mortality risk and suffer from several comorbidities includ-
ing psychosis and other mental illnesses, neurological disor-
ders, cardiovascular dysfunctions, sexually-transmitted dis-
eases, and blood-borne viral infections4. Moreover, the im-
pact on society is large because of the association between
stimulants use and offending5.
Recent data suggest that people affected by stimulant use
disorders are increasingly seeking out treatment2. Usually
these patients do not require inpatient care because with-
drawal syndromes are not severe or complex, and most can
be safely treated in outpatient programs. Psychiatric and psy-
chological management is advocated as the best evidence-
based option for these patients and aims to: 
• motivate the patient to change; 
• establish and maintain a therapeutic alliance with the pa-
tient;
• assess the patient’s safety and clinical status;
• manage the patient’s intoxication and withdrawal state;
• develop and facilitate the patient’s adherence to a treat-
ment plan; 
• prevent the patient’s relapse; 
• educate the patient about substance use disorders;
• reduce the morbidity and sequelae of substance use dis-
orders.
Clinical guidelines recommend psychosocial interven-
tions as the treatments of choice for all stimulant use disor-
ders6-9, and there is no evidence of differential effect for any
psychosocial intervention in the management of patients us-
ing distinct stimulants10. The development and assessment of
psychosocial interventions for substance use disorders has
been a priority of the National Institute on Drug Abuse for
over 20 years11. However, a key limitation of studies investi-
gating psychosocial interventions is that even well designed
randomized controlled trials are subject to biases that can
falsely increase the likelihood of a positive outcome12-14. A
recent systematic review and meta-analysis provided encour-
aging results on the efficacy and acceptability of all types of
psychosocial interventions for stimulant use disorders15;
however, this study did not compare qualitatively the various
treatments.
In this paper, we performed a systematic review and qual-
itative synthesis of all psychosocial interventions assessed in
randomized controlled trials. Our aim is to provide clinicians
with a comprehensive description of all the available psy-
chosocial interventions for stimulant use disorders and re-
port the most recent evidence-base for them.
METHODS
Literature search
We performed an extensive computer literature search of
peer-reviewed articles about psychosocial interventions in
stimulant use disorders on the following databases:
Cochrane Drugs and Alcohol Group Register of Trials, Med-
line, Embase, CINAHL, ISI Web of Science, PsycINFO. The
search strategy is available as appendix 1 in the supplemen-
tary material. We added a hand-search of the reference list of
retrieved articles. All searches included non-english litera-
ture.
Study selection
We included all randomized controlled trials comparing
psychosocial interventions, either alone or in combination
with pharmacological therapy, against no-treatment, waiting
list, or any other psychosocial treatment. We only accepted
studies performed in adults (>18 years old) with a diagnosis
of stimulant use disorder according to the Diagnostic and Sta-
tistical Manual of Mental Disorders (DSM) -III, -IV or -5 or
the International Classification of Diseases (ICD) -9 or -10. 
We excluded review articles, editorials, letters, comments,
conference proceedings, case reports, and case series; studies
dated before 1990 if the system used for the diagnosis did not
use operationalized criteria, but only disease names with no
diagnostic criteria (i.e. ICD-9); trials lacking a control group.
Three authors (FDC, GLDA, MC) independently re-
viewed the titles and abstracts of the articles retrieved, ap-
plying the inclusion and exclusion criteria; then, they exam-
ined the full-texts to confirm the studies’ eligibility for inclu-
sion. Disagreements were resolved by consensus. 
Data extraction
We designed and used a structured template to ensure
consistency and we systematically appraised each study. Da-
ta extracted embraced characteristics of the studies (i.e. first
author, publication year, journal), of the participants (i.e.
mean age, diagnosis), and of the interventions (i.e. types of
treatment, comparisons, duration of treatment, duration of
follow-up). 
Qualitative synthesis
Two authors (CC, RDG) retrieved the manuals for each
psychosocial intervention included and summarized the key
principles. Then, they integrated these data with the main
findings from all the randomized controlled trials previously
selected. Risks of bias in the included studies were assessed
using the tool described in the Cochrane Collaboration
Handbook as a reference guide, which pays particular atten-
tion to random sequence generation, allocation concealment,
blinding of participants and personnel, blinding of outcome
assessment, incomplete outcome data and selective report-
ing16. This tool allows a rating of “low”, “unclear” or “high”
risk of bias. 
RESULTS
Our computer-based search retrieved 6 728 records. After
removing 2 660 duplicates, further 4 068 articles were ex-
cluded because they did not meet the required criteria, leav-
ing 108 full-text articles included. Further six studies were
added from trial registries and one additional article was re-
trieved from hand-search. A total of 115 articles correspon-
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ding to 91 randomized controlled trials (RCTs) were finally
included in this review (see figure 1 in the supplementary
material). 
The characteristics of the studies included is reported in
Table 1, while in Table 2 we summarized the main differen-
tial elements of the psychosocial therapies included. A risk of
bias summary is available as Table 3 in the supplementary
material, while the references of all the included RCTs are
listed in the Appendix 2 in the supplementary material.
Overall, contingency management (CM) was investigated
in 45/91 studies (49%), cognitive behavioral interventions in
32/91 studies (35%), community reinforcement approach
(CRA) in 9/91 studies (10%), 12-step program (12SP) in 8/91
studies (9%), meditation-based interventions (MbI) and
physical exercise (PhE) in 6/91 studies (7%), supportive ex-
pressive psychodynamic therapy (SEPT) in 3/91 studies
(3%), interpersonal psychotherapy (IPT) in 3/91 studies
(3%), family therapy (FT) in 3/91 studies (3%), motivational
interviewing (MI) in 11/91 studies (12%), drug counselling
(DC) in 10/91 studies (11%). It should be noted that some
studies examined numerous or combined interventions at
the same time (see Table 1). 
Contingency management (CM)
Theoretical background
Contingency management (CM) is a behavioral interven-
tion that emphasizes the positive reinforcement of healthy
behaviors, whereby addicted patients are incentivized with
rewards for providing drug-free urine samples17. It differs
from non-contingent reward where patients are remunerat-
ed irrespective of the results of the urine drugs screening.
Similarly to drugs, CM applies positive reinforcers to absti-
nent behavior and immediately conveys relief and satisfac-
tion. The purpose is to promote abstinence and improve the
welfare of an often-deprived population. 
Trials
A wealth of studies examined CM in stimulant use disor-
ders.
a) Cash rewards
There is little research on CM using cash rewards, which
showed that a cash-based CM combined with bupropion18
or topiramate19 improved outcomes in cocaine users com-
pared to non-contingent rewards, regardless of the use of
medication.
b) Voucher rewards
Since cash rewards may be spent on substances, most CM
approaches offered vouchers instead. Voucher-CM was
not inferior to cash-CM in improving cocaine abstinence
and treatment attendance, regardless of the high or low
value of the rewards20,21. Cocaine and crack cocaine users
responded to voucher-based CM with increased accept-
ability and abstinence rates22 and reduced craving23. The
use of CM coupons of escalating value was associated
with sustained cocaine and opiate abstinence in a popula-
tion of methadone-maintained patients24,25. Conversely,
Rawson et al.26 and Menza et al.27 reported an improve-
ment in short-term outcomes that was not maintained at
follow-up, while Umbricht et al.28 did not show any differ-
ence in abstinence between voucher-based CM and non-
contingent rewards.
c) Prize rewards
Stakeholders underlined that the cost of vouchers paid by
the health system can be high on a large scale; therefore,
another approach consisted of awarding prizes and lottery
tickets attracting numerous low-value and limited high-
value rewards. Petry et al.29 showed that voucher and
prize CM were equally effective in cocaine-using
methadone patients, and prize-based incentives improved
abstinence outcomes30 and psychiatric comorbidities31,32.
Low-cost prizes can increase abstinence33-35, but higher-
magnitude prizes proved better on the long term36,37.
Longer periods of prize-CM promoted longer durations
of abstinence38 and increased post-exposure prophylaxis
in men who have sex with men using methamphetamine39.
However, some studies showed that prize-based CM did
not significantly improved abstinence in stimulant use dis-
orders, but it did in opioid40 and alcohol use41.
d) Other rewards
Addicted patients may struggle with failing the lottery
draw or can be inadvertently fed into a gambling addiction;
hence some alternative CM strategies were devised. In case
of stimulant- and opioid-use comorbidity, buprenorphine
doses were provided as CM rewards, resulting in increased
abstinence at follow-up compared to CM vouchers42,43 used
an employment-based reinforcement that proved effective
in long-term abstinence, but another study showed low en-
gagement with a similar approach44.
Cognitive behavioral interventions
Theoretical background
Cognitive behavioral interventions are based on cogni-
tivism and behaviorism paradigms. Cognitivism assumes that
mental disorders are triggered by unhealthy beliefs45,46:
thoughts such as “I need to escape”, “I cannot deal with this
unless I am high”, and “I deserve to get high considering what
I am going through” are commonly noted to precede stimu-
lants use47. Behaviorism maintains that most human traits and
actions are learned48, therefore stimulants use can be consid-
ered a learned behavior47. Cognitive behavioral interventions
aim to modify cognitions and behaviors that lead to substance
misuse. Trials in stimulant use disorders included cognitive
behavioral therapy (CBT), gay-specific cognitive behavioral
therapy (G-CBT), and relapse prevention (RP).
a) Cognitive behavioural therapy (CBT)
Theoretical background
CBT for stimulant use disorders is a short-term psy-
chotherapy divided into functional analysis and coping-skills
training47. 
Functional analysis is based on the antecedents, behavior,
and consequences model46. Initially, patient and therapist ex-
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Table 2. Differential elements of psychosocial therapies included.
Therapy Elements of therapy Duration Target population
Cognitive
behavioural
coping skill
treatment (CBT)
– Functional analysis of substance use: history, when it occurs,
triggers, frequency, intensity, motivation and resources about
change
– Coping skills training: role play to adopt new different strategies
(positive modelling), systematic analysis of the short and long
term consequences of substance use (operant conditioning), to
increase awareness, avoidance of high-risk situations (classical
conditioning)
12 to 16 sessions,
usually over 12
weeks
Individuals with
psychostimulant addiction 
Gay specific
cognitive
behavioural
therapy (GCBT)
– Functional analysis of substance use and coping skills training
– Specific HIV prevention
48 sessions in 16
weeks or 24
sessions in 8 weeks
Individuals homosexual or
bisexual with
methamphetamine use
Relapse
prevention (RP)
– Specific interventions: to identify and cope with high-risk
situations, enhance self-efficacy, to eliminate positive myths and
placebo effect assumptions about the drug, lapse management
– Global interventions: to reduce stressful lifestyle, promote
“positive addictions”, to cope with craving
12 weeks Individuals who have received,
or are receiving, treatment for
addictive behavior problems.
RP can be used to foster initial
abstinence or as a maintenance
strategy
Community
reinforcement
approach (CRA)
– To identify and address causes of drug abuse to more complex
relational and psychiatric problems
– Functional analysis
– Coping skill training
– Eventually vouchers with urinalysis monitoring two-three times
a week
– Eventually meetings outside the office
24 weeks, twice
weekly counselling
sessions for the first
12 weeks, then once
weekly
Cocaine use, 18 years or older,
living within a reasonable
distance of the clinic, due to
the intensive nature of the
intervention
Contingency
management
– Positive reinforcement of positive behaviours and attitudes
– Using objective measures such as urinalysis
– Giving prizes: vouchers, lottery tickets, methadone doses (in
case of comorbidity with opioid addiction)
– No relationship with a therapist
Not specified Individuals with
psychostimulants addiction.
May not be appropriate for
people with problematic
gambling.
Supportive-
expressive
psychodynamic
therapy
– To develop awareness of  personal hopes or needs from a
relationship (wish), personal expectations and experiences from
others (Response from Others - RO), and personal reaction to
this response (Response from Self - RS)
– To be aware of how repetitive patterns are related to past
relationship with the caregivers, and to the present as triggers
for craving
– To work with transference and countertransference
6-month active
phase and 3-month
booster phase,
During the first 3
months sessions are
held twice per week,
during the next 3
months sessions are
held weekly, during
the booster phase 1
session is held each
month
Individuals with
psychostimulants addiction,
who can achieve initial
abstinence
Interpersonal
psychotherapy
– To develop the need to stop using cocaine and to abandon the
ambivalence about the substance
– Comparison between the negative and positive effects of drug
abuse
– To recreate the thoughts and emotions that precede the use of
cocaine
– To manage the impulsiveness
– Analysis of interpersonal problems that have caused and
maintained drug abuse and
– Identify new functional solutions in preference of cocaine use
12-16 sessions Individuals with
psychostimulants addiction,
who feel the abuse is
secondary to interpersonal
problems
Family therapy – To focus on relationships in the family system rather than the
drug and the patient themselves
– To redefine the addiction and its functions at the family life
cycle actual stage
– To restructure the system to maximise the potential in each
member
– To work on family’s boundaries
– To work on present and past
– To identify repetitive family patterns
5 months Individuals with
psychostimulants addiction
who feel the addiction stems
from and is maintained by
family patterns
The 12-step
program
– Based on self-help group
– Spiritual and pragmatic vision embraced in twelve steps:
acceptance of being addicted and surrender to a “higher Power”
Not specified Individuals who desire to stop
using cocaine and all other
mind-altering substances
(continued)
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plore the features of historical drug use. They move next at
analyzing maladaptive behavioral patterns including timing,
frequency, and intensity of misuse, as well as any environ-
mental, psychological, or somatic trigger for craving. Finally,
emerging personal and interpersonal resources, motivation
for change, and future goals are discussed. 
Coping-skills training works on basic learning mecha-
nisms that led to stimulants use in the first place, such as
modeling49,50, classical conditioning51, and operant condition-
ing52. Modeling theory suggests that people learn new be-
haviors by watching and then imitating others, so patients ex-
posed to negative models of drug use within their family or
peer group will shape their behavior accordingly and devel-
op an addiction. On this basis, CBT aims to replace that neg-
ative model with a positive one conveyed by the therapist; al-
so, new skills such as rejecting an offer of drugs and manag-
ing relationships with peer users are presented through role-
play in a therapeutic setting and then routinely practiced by
patients. Classical conditioning occurs when an uncondi-
tioned stimulus is paired with another conditioned stimulus,
producing a conditioned response; thus, the recurrent use of
stimulants (i.e. the unconditioned stimulus) can be associat-
ed with places, times, money, and other triggers (i.e. the con-
ditioned stimuli) that will elicit craving for substances (i.e.
the conditioned response). Here, CBT is used for increasing
awareness of these unhelpful mechanisms and facilitate the
avoidance of high-risk situations. Operant conditioning re-
quires active involvement of the subject because future be-
havior relies on the consequences of past behavior; in stimu-
lant use disorders, the intake of cocaine and amphetamines is
reinforced by its most desired consequences such as in-
creased energy and efficiency, euphoria, grandiosity, and dis-
inhibition. A CBT approach encourages patients to examine
the short- and long-term outcomes of stimulant use, which
turn out to be negative in most cases (i.e. a negative rein-
forcement); moreover, the therapist can redirect patient’s
behavior to other pleasant endeavors such as hobbies, work,
and relationships (i.e. positive reinforcement).
Trials
Many trials assessed CBT in stimulant use disorders. CBT
was associated with improved outcomes in cocaine53, crack
cocaine54, and methadone-maintained cocaine users26 with
lasting effects. Even non-intensive CBT delivered fortnight-
ly over 12 weeks was effective in cocaine use55, and Baker et
al.56,57 obtained comparable results with a brief CBT inter-
vention plus psychoeducation via self-help booklets in am-
phetamine users. A CBT strategy focusing on the negative
effects of misuse significantly reduced craving for the sub-
stance in methamphetamine58 and cocaine users59. Carroll47
and Carroll et al.11 showed that combined CBT and disulfi-
ram was effective in cocaine use disorder irrespective of con-
current alcohol misuse. In contrast, one study reported that
CBT was less effective than counseling in reducing days of
cocaine use and drug-related problems60, whilst another
compared CBT with other interventions, but no abstinence
outcomes were reported for it61. As CBT can be resource-
consuming, some researchers attempted strategies for in-
(continued) - Table 2.
Therapy Elements of therapy Duration Target Population
Mindfulness
based stress
reduction
(MBSR)
– Body scan, sitting meditation and hatha yoga practice
– To develop greater attention to internal and external
experiences as they occur moment by moment
– To adopt non-judgement of, and openness to, current
experience, instead of trying to modify or suppress it
– Promote detachment and lower reactivity to stimuli that lead to
relapse, as opposed to complete avoidance of them
8 weeks program
comprised of
weekly two and a
half hour sessions, a
one day retreat and
daily homework
(about 45 minutes)
Individuals with
psychostimulant addiction
who can renounce to
traditional talking based
therapy
Mindfulness
based relapse
prevention
(MBRP)
– Integration of relapse prevention and mindfulness practice
– To develop awareness and acceptance of thoughts, feelings, and
sensations
– To utilize these mindfulness skills as an effective coping strategy
in the face of high-risk situations
8 weeks program Individuals with
psychostimulant addiction
who can renounce to
traditional talking based
therapy
Motivational
interviewing
– Manage the patient’s ambivalence about change
– Reflective listening, understanding and empathy
– Highlight discrepancies between the client’s current situation
and their hopes for the future,
– To allow them to identify their own motivation
– Enhancing motivation
2-4 sessions Initial tool in individuals with
psychostimulant use who feel
poorly motivated 
Individual
counselling
– Focuses on the present, with short-term and behavioural goals
related to the symptoms of substance abuse
– Support to achieve and maintain abstinence
– Recognising and avoiding triggers,
– Enhancing motivation,
– Developing new and more effective coping strategies
– Using objective measures such as urinalysis
36 sessions over 6
months
Cocaine addicts with the
exception of opiates if
methadone maintenance is to
be used
Group drug
counselling
– Phase one: psycho-educational group of 12 standard sessions to
improve knowledge about addiction and the recovery process.
– Phase two: problem solving
34 sessions (once a
week)
Early and middle stages of
recovery from addiction,
preferred in combination with
an individual treatment
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creasing availability. Group CBT failed to show any differ-
ence against usual treatment62. A preliminary study by Ke-
oleian et al.63 used a CBT-based text-messaging intervention
for methamphetamine users that showed high feasibility and
acceptability. Carroll et al.64, delivered a computer-based
CBT to cocaine users on methadone, reporting easy accessi-
bility and increased abstinence with lasting effects. Finally,
another study used a self-guided web-based intervention
based on CBT and motivational interviewing principles over
6 months via a free-to-access site for amphetamine users, but
this failed to show improvement in drug use and engagement
remained low65.
b) Gay-specific cognitive behavioral therapy (G-CBT)
Trials
Cognitive behavioral interventions can be targeted to spe-
cific populations: G-CBT was adapted for men who have sex
with men affected by methamphetamine dependence by
Shoptaw et al.66,67. In addition to standard cognitive-behav-
ioral principles, G-CBT considered cultural aspects of
methamphetamine use by men who have sex with men in-
cluding triggers such as circuit parties and sex clubs, and ob-
tained significant and sustained improvements in both drug
use and prevention of HIV.
c) Relapse prevention (RP)
Theoretical background
Once abstinence is achieved, cognitive behavioral inter-
ventions aim to prevent further relapses. The RP model
views relapse as secondary to difficulty in coping with imme-
diate determinants (i.e. negative emotional states, relational
problems, social pressures, lapses) and to covert antecedents
(i.e. life-style, urges and craving)68. Through RP work, pa-
tients learn to identify high-risk situations such as lapses that
are associated with guilt and other negative emotions, even-
tually leading to relapses. Lapse management uses cognitive
restructuring to recognize lapses and relapses not as failures
but opportunities to learn from mistakes. RP interventions
also focus on the antecedents and aim to reduce stressful life-
style factors by eliminating all items associated with stimu-
lants use and promoting “positive addictions” such as medi-
tation, relaxation training, and other recreational activities. 
Trials
RP reduced cocaine and other drugs use post-treatment69,
and it was more effective in those whose drug use was the
most severe70-72. Group and individual approaches showed
comparable results73. However, McKay et al.74 stressed that
RP was useful only after abstinence was fully achieved.
d) Cognitive behavioural interventions plus CM
Trials
Cognitive behavioral interventions are often combined
with CM with a view of increasing the engagement with ther-
apy. CBT plus CM increased abstinence in cocaine users75, es-
pecially when rewards were arranged in conjunction with
therapeutic progress76. Also, combining RP with CM im-
proved outcomes in cocaine users who had achieved initial
abstinence77. Rawson et al.26,78 reported superior short- and
long-term outcomes for CBT and CM respectively, but no ad-
ditive effect was observed. On the contrary, combined CBT
and CM obtained significantly better outcomes than CBT or
CM alone in cocaine79,80 and methamphetamine users67. Mil-
by et al.81 studied a population of homeless cocaine users and
showed that the combination of a housing- and employment-
based CM with cognitive behavioral interventions lead to
more durable abstinence. A preliminary study by Carrico et
al.82 highlighted the feasibility of CBT plus CM in a high-risk
population of Cambodian female sex workers using amphet-
amines who live in a resource-limited area.
Community reinforcement approach (CRA)
Theoretical background
The community reinforcement approach (CRA) is a multilayered
intensive intervention delivered over 24 weeks and adapted to treat
cocaine and amphetamines addiction83. It teaches drug avoidance
skills, encourages lifestyle changes, gives relationship counseling, and
addresses comorbid substance use and psychiatric disorders. As in
CBT, it involves functional analysis and coping-skills training. Social, fa-
milial, recreational, and vocational reinforcers are largely used, pro-
viding a comprehensive and supportive structure to treatment.
a) CRA alone
Trials
Only one trial used CRA alone, showing better retention
and abstinence rates, and improvements in addiction severi-
ty scores after 24 weeks of treatment84. 
b) CRA plus CM
Trials
Incentives such as vouchers and out-of-treatment sessions
(e.g. meetings outside the office hours) are frequently added
to improve treatment compliance. Numerous studies by Hig-
gins et al.17,85-87, García-Rodríguez et al.88, García-Fernández
et al.89,90 showed that CRA plus CM was effective, had in-
creased retention rates, and improved psychosocial out-
comes in cocaine users, although this was not demonstrated
at follow-ups longer than 6-12 months after the end of treat-
ment. These findings were confirmed in cocaine users of any
socioeconomic status91. However, another study failed to
show any superiority of CRA when added to CM92.
12-step program (12-SP)
Theoretical background
The 12-step program (12-SP) was originally designed for
alcoholism93 and then adjusted to several other substance
use disorders including cocaine and amphetamines. Contrar-
ily to other treatments, it considers addiction as a chronic ill-
ness that can be controlled, but never cured. It is largely
based on spiritual and relational principles applied to a fel-
lowship of peers associated by the willingness to fight addic-
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tion. All members share a transcendent yet pragmatic vision
embraced in twelve steps (see box 1 in the supplementary
material), including the acceptance of being addicted and the
surrender to a “higher Power”, often but not necessarily in-
terpreted as God. The self-help group reduces social isola-
tion and conveys support and empathy from people facing
similar problems, all in complete anonymity. However, com-
plex group dynamics pose frequent challenges, especially be-
cause most members are not trained to work on this aspect.
Moreover, group therapies normally do not allow enough
time to address deeper individual experiences. A 12-step fa-
cilitation therapy was therefore developed with the aim to
improve participation and involvement in the 12-SP94. This is
a structured, individual, and time-limited intervention deliv-
ered by a trained psychotherapist.
a) 12-SP alone
Trials
Trials of 12-SP and 12-step facilitation in stimulant use
disorders achieved modest95 or mixed96 results. Two studies
showed that 12-SP and cognitive behavioral interventions
were equally effective in patients addicted to cocaine and
alcohol69,97. Maude-Griffin et al.54 obtained opposite results
but highlighted a potential benefit from 12-SP in the spe-
cific subgroup of African American with strong religious
beliefs.
b) 12-SP plus other interventions
Trials
Few studies on combined interventions are reported in lit-
erature. The effectiveness of 12-SP plus counseling in cocaine
use disorder was supported by Weiss et al.61, who reported
that active participation predicted less cocaine use. Higgins
et al.85 compared 12-SP plus non-contingent reward with
CRA plus CM, but the former resulted in worse outcomes.
However, when CM was combined with either 12-SP or
CRA, no difference between treatments was found92. 
Meditation-based interventions (MbI) 
and physical exercise (PhE)
Meditation-based interventions (MbI) and physical exer-
cise (PhE) share several theoretical underpinnings and
therefore are reported together.
a) Meditation-based interventions (MbI)
Theoretical background
Meditation refers to a broad variety of practices including
body scan, yoga, and mindfulness meditation, whereby indi-
viduals train their minds to pay greater attention to internal
and external experiences as they occur98,99. It is not designed
to suppress dysfunctional behaviors, but encourages the
adoption of a non-judgmental approach to stressful experi-
ences, leading to detachment and lower reactivity to stimuli
associated with relapse and reduced distress. It can be deliv-
ered in group and then self-applied, so the overall cost is low.
The engagement with MbI can vary as some patients may
have a positive attitude towards it, but others may be reluc-
tant to abandon traditional talking-based therapies.
Trials
MbI for stimulant use disorders were examined in 3 trials.
Smout et al.100 devised a modified version of the acceptance
and commitment therapy101,102, integrating aspects of mind-
fulness training and behavioral therapy and consisting of
weekly 60-minute individual sessions for 12 weeks. This was
tested on a sample of methamphetamine users and showed
results comparable to those of a CBT intervention of the
same intensity. Chen et al.103 used a different MbI to treat co-
caine addiction, which involved adjusting the breath to near-
resonant frequency, regulating the mind with inward atten-
tion and guided imagery, and ear acupressure. This treatment
was confirmed to increase abstinence and to reduce craving
and anxiety when compared to usual treatment. Yoga medi-
tation was used on a population of crack cocaine users with
comorbid HIV, showing high feasibility and acceptability as
well as modest improvements in measures of quality of
life104. Finally, a recent trial developed a Mindfulness Based
Relapse Prevention and used it in addition to CM for pa-
tients with stimulant use disorders, showing declining stimu-
lant use among those with comorbid depressive and anxiety
disorders105.
b) Physical exercise (PhE)
Theoretical background
PhE is an intervention that is thought to impact directly
on stimulant use and mediates important health-related out-
comes such as withdrawal symptoms, mood, sleep, cognitive
function, and quality of life106. 
Trials
A few studies recently assessed various PhE interventions
in stimulant use disorders. Zhu et al.107 used tai-chi, a tradi-
tional Chinese sport classified as a moderate exercise, on am-
phetamine users, reporting significant improvements on all
domains of a quality of life for drug addiction questionnaire.
Rawson et al.108 showed that a structured PhE program and
health education for methamphetamine users decreased sub-
stance use among lower severity patients and significantly re-
duced comorbid depressive symptoms. However, walking
and running, in addition to a baseline intervention of CBT
and rewards including cash and sport equipment, improved
the fitness of cigarette-smoker patients with concurrent co-
caine use disorder, but did not significantly improved absti-
nence and craving from cocaine109. Likewise, a recent study
failed to show any significant difference in abstinence rates
between PhE and health education110.
Supportive-expressive psychodynamic therapy (SEPT)
Theoretical background
All psychodynamic approaches derive from Freud’s psy-
choanalytic model; amongst these, supportive-expressive
psychodynamic therapy (SEPT) is the only evidence-based
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for stimulant use disorders111. This psychotherapy was adapt-
ed for cocaine misuse by Mark and Luborsky112. It uses a
“core conflictive relationship theme” based on the patients’
hopes and needs from relationships (i.e. wish), the reactions
elicited from others and their experience of them (i.e. re-
sponse from others), and their own reactions to the latter (i.e.
response from self). According to this model, people who
misuse cocaine often are or anticipate being criticized, re-
jected, mistreated, controlled, and humiliated (response
from others). Consequently, they feel ashamed, guilty, help-
less, suspicious, and angry (response from self). Cocaine is
used as a means for regulating their pain, but this makes their
targets (wish) difficult to recognize because of the effects of
addiction. They refuse to take responsibility for their nega-
tive actions and are unable to consider the needs of others,
which further reinforces cocaine use. The therapist supports
the patient in viewing this aspect as another response from
self and promotes the expression of deeper wishes such as
being accepted, understood, loved, and independent. Pa-
tients become progressively more conscious of the three
components of the core conflictive relationship theme,
whereby they appreciate how their past and present rela-
tionships are linked to their cravings and relapses. As in all
psychodynamic therapies, the analysis of transference and
countertransference is framed within the approach.
Trials
Trials on SEPT for stimulant use disorders are scarce and
only addressed cocaine misuse. A multimodal intervention
based on the principles above determined significant im-
provements in drug use and psychological functioning113.
However, another study reported worse outcomes for co-
caine users treated with SEPT compared to counseling60 al-
though a following analysis suggested that SEPT can be par-
ticularly effective to those patients who can achieve initial
abstinence. Weiss et al.61 described the use of SEPT amongst
other interventions, but no results about this therapy were
reported.
Interpersonal psychotherapy (IPT)
Theoretical background
Interpersonal psychotherapy (IPT) maintains that psychi-
atric disorders are caused and sustained by disturbances in
interpersonal functioning114. Rounsaville et al.115 adapted
IPT for ambulatory cocaine users and set two goals for ther-
apy: reduction or cessation of cocaine use, and improvement
in interpersonal functioning. Initially, patient and therapist
agree a contract where the former recognizes the necessity of
abstinence and abandons any ambivalence about the sub-
stance, whilst the latter can support in decision-making by
comparing the negative and positive effects of drug misuse.
Patients are prompted to recreate those thoughts and emo-
tions preceding cocaine use and discuss strategies for man-
aging their impulsiveness and avoiding social contexts that
can be triggers. Attendance to self-help groups is encouraged
to replace the addiction to drugs with engagement in group
relationships. Usually, further work is required to achieve
better interpersonal relationships, because patients often see
drugs as having an important role in navigating interperson-
al problems; for instance, cocaine is used when facing dis-
putes, transitions, shortfalls, and grieves and to become more
sociable, friendly, self-confident, and sexually disinhibited.
Therapist and patient investigate these issues and try to iden-
tify alternative coping mechanisms instead of cocaine use.
IPT is often considered a comprehensive approach to sub-
stance use disorders because it focuses on both drug misuse
and interpersonal functioning; however, if the misuse is not
directly linked to interpersonal problems, the applicability of
IPT is poor. 
Trials
Only 2 studies tested IPT in cocaine use disorder. Carroll
et al.70 delivered weekly IPT sessions of 50-60 minutes for 12
weeks and reported significantly improved abstinence com-
pared to CBT in the most severe users. However, a following
trial by the same authors disconfirmed this result11.
Family Therapy (FT)
Theoretical background
Family therapy (FT) poses emphasis on the relationships
within the family system, including those who live in the
household or are closely related, rather than the drug or the
individual patient116. Firstly, addiction is reviewed in the con-
text of the current family situation; for instance, an adoles-
cent using cocaine can shift parental attention from a latent
marital conflict to his drug problem, therefore preserving a
degree of stability in the family. This assumes that family sys-
tems naturally reach a homeostatic state that may inadver-
tently maintain maladaptive patterns of behavior. The pa-
tient’s self and family blend in, producing separation anxiety
and fear to grow, so that the whole family system is trapped
at a developmental stage. The therapist’s task is to stimulate
a restructuring of the system to maximize the potential of
each family member. Enmeshment and disengagement are
additional therapeutic avenues where family members can
establish or loosen boundaries as appropriate117. Patients are
encouraged to draw a genogram of their family history for at
least three previous generations; then, they are supported to
identify recurrent maladaptive family patterns and develop
an understanding of how these can be linked to their behav-
ior, including drug misuse118.
Trials
There are few trials using FT specifically in stimulant use
disorders. Hoffman et al.119 included an unstructured sup-
portive FT in their study, where they combined several psy-
chosocial interventions for treating a sample of cocaine
users; however, no specific data for each treatment were pro-
vided. Kang et al.120 used weekly sessions of FT in a similar
population, but no beneficial effect was observed. Both Hoff-
man et al.119 and Kang et al.120 used an unstructured sup-
portive type of FT. On the contrary, Slesnick and Zhang121
developed a more structured ecologically-based FT (EBFT),
which is a 12-session family system therapy, based on a social
ecological theoretical perspective122. Slesnick and Zhang121
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showed that EBFT is associated with a quicker decline in co-
caine use in mothers using substances.
Motivational interviewing (MI)
Theoretical background
Motivational interviewing (MI) is an evolution of Rogers’
person-centered counseling123 integrated with cognitive and
behavioral strategies124, which argues that poor motivation
and resistance contribute significantly to adverse outcomes in
drug users. MI is a brief intervention, usually delivered in 2-4
sessions, aiming to manage the patient’s ambivalence about
change through reflective listening, understanding, and empa-
thy. Contrarily to other cognitive behavioral interventions, di-
rect challenging is avoided as it could elicit defiance at this
stage. Instead, discrepancies between the patients’ situation
and their hopes for the future are highlighted, leading to a
constructive discussion where the therapist shows patience
and optimism and provides constant support in self-efficacy.
Eventually, patients become more capable of identifying and
enhance their motivation and readiness to change.
a) MI alone
Trials
There are several studies on MI for stimulant use disor-
ders. Two articles reported that a single session of MI, either
alone or in combination with written health risk information,
did not prove beneficial in respectively crack cocaine users
on methadone maintenance125 and in a heterogeneous popu-
lation of stimulant users126. Stein et al.127 compared 4-session
MI to an assessment control and concluded that the former
was better at reducing days of cocaine use amongst the heav-
iest community-based users. Polcin et al.128 delivered an un-
usually intensive 9-session intervention to patients with
methamphetamine dependence, reporting a reduction in
drug use and alleviated co-occurring psychiatric problems.
Computerized versus in-person MI were compared with a
view of further increasing the availability of this brief inter-
vention, but no reduction in stimulants use was elicited re-
gardless of treatment129.
b) MI plus other interventions
Trials
MI is frequently combined with other brief interventions.
Srisurapanont et al.130 assessed MI and health education in
young students with methamphetamine dependence, report-
ing short-term benefits such as fewer days of drug use. The
same combination was also trialed in a sample of crack co-
caine users with comorbid HIV and poor adherence to anti-
retroviral therapy, showing improved compliance with treat-
ment and fewer drug problems131. A single 50-minute session
known as motivational enhancement therapy132 combining
MI with personalized feedback about a preliminary assess-
ment and health education, showed improved outcomes
when used on ecstasy users133. Goncalves et al.134 integrated
MI with chess playing and showed that this can be an effec-
tive intervention in improving executive functions, associated
with abstinence outcomes, in a population of cocaine users.
Other 2 studies combined brief CBT with MI respectively for
cocaine and amphetamine users, but results on abstinence
outcomes were either inconclusive135 or not reported136. 
Drug counseling (DC)
Theoretical background
Individual drug counseling (IDC) for stimulant use disor-
ders is largely inspired by 12-SP principles, seeing addiction
as a disease damaging the person physically, mentally, and
spiritually137. It is a semi-structured, time-limited interven-
tion of 36 sessions over 6 months, which focuses on the pres-
ent and sets short-term goals. Initially, patients need to ac-
cept having an addiction, seeing this as a disease, and aiming
to abstinence. Then, they learn to recognize and avoid trig-
gers, develop new coping strategies, and use objective meas-
ures of abstinence such as urinalysis. Finally, the counselor
supports them to enhance their motivation and promotes
lifestyle changes to prevent relapse and maintain recovery as
a lifelong process. Drug counseling can also be delivered in
groups (GDC) and it usually involves two phases138. The first
12 sessions consist of a structured psychoeducational group
to improve knowledge about addiction and learn about the
recovery process; a second phase between sessions 12-36 ed-
ucates on problem-solving techniques. As for any group ther-
apy, it should offer a warm atmosphere, where each member
can express opinions, problems, feelings and support; howev-
er, domination by an individual or isolation are common pit-
falls. Both IDC and GDC usually encourage additional par-
ticipation to 12-SP groups such as cocaine or amphetamine
anonymous.
Trials
IDC and GDC are very commonly used in stimulant use
disorders, although many available trials employed it as a
baseline intervention29,54 or in conjunction with several oth-
er treatments139 without providing specific outcomes data.
Gottheil et al.140 compared IDC, IDC plus GDC, and an in-
tensive outpatient program for cocaine users, reporting im-
provements in drug use and severity of associated problems
for all three interventions with no significant differences be-
tween treatments. Crits-Christoph et al.60 showed that a com-
bination of intensive IDC and GDC was superior to psycho-
dynamic and cognitive behavioral approaches in reducing
days of cocaine use and drug-related problems. Weiss et al.61
reported that IDC was beneficial in cocaine users both in im-
proving drug outcomes and in promoting participation to 12-
SP sessions. Rawson et al.141 used a complex and intensive
“matrix model” that combined 4 sessions of IDC, 16 weeks of
twice-weekly group CBT, 12 sessions of family education
groups, 4 sessions of social support groups, encouragement to
attend 12-SP, and weekly testing for alcohol and stimulants
on a large sample of methamphetamine users, showing sig-
nificant improvements during the treatment phase that were
not maintained on the longer-term. Other studies used tele-
phone monitoring and adaptive counseling on cocaine users
and showed that, when vouchers are used as rewards, en-
gagement with therapy increased and abstinence outcomes
improved141-143.
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DISCUSSION AND CONCLUSIONS
In this article, we systematically reviewed and qualitative-
ly synthesized all psychosocial interventions studied in ran-
domized controlled trials. Currently, this is the most com-
plete review available on this subject.
There are several theoretical differences between thera-
pies. Cognitive and behavioral models predominate in ran-
domized controlled trials, possibly because they are more
likely to rely on standardized delivery protocols. CM, cog-
nitive behavioral interventions, and CRA see addiction as
deriving from dysfunctional thoughts and maladaptive
learned behaviors, which they aim to modify through cog-
nitive and behavioral techniques such as functional analy-
sis, coping-skills training, and operant conditioning, with or
without the addition of social support. The 12-SP acknowl-
edges these issues, though does not address them in a sys-
tematic fashion, but adds a spiritual element that promotes
acceptance of the disease. Similarly, MbI and PhE include
practices focusing on understanding, modulating, and exert-
ing inner bodily and spiritual energies and external experi-
ences as a mean to reach acceptance and change. Relation-
ships are central to the formulation of stimulant use disor-
ders for SEPT, IPT, and FT, which differ because of their
emphasis on the study of transference and countertransfer-
ence, interpersonal functioning, and family systems respec-
tively. Finally, MI and DC are classic counseling approach-
es because they refuse to assign a “sick role”, encouraging
the development of immediate modifications of attitude
and behavior. 
Moreover, practical differences can affect the choice of
treatment. Some therapies are manualized and consistently
available in the public health sector or via charities (e.g. CBT,
12-SP), whereas others are based on common theoretical prin-
ciples but are not standardized (e.g. RP, SEPT), and therefore
it is difficult to produce evidence to promote their diffusion.
Clinicians and patients should discuss the pragmatic aspects of
treatment delivery beforehand, because psychosocial inter-
ventions may vary in terms of intensity (e.g. low in DC, high in
cognitive behavioral interventions), duration (e.g. brief in cog-
nitive behavioral interventions, extended in SEPT and DC,
lifelong in 12-SP), modality (e.g. IDC vs GDC or 12-SP), and
media (e.g. face-to-face in most psychotherapies, very limited
contact in CM, online or telephone in DC).
The group of patients suffering from stimulant use dis-
orders is heterogeneous. Several authors highlighted how
specific psychosocial interventions may work best for par-
ticular subgroups of stimulant users or for a particular
phase of the disorder, and indeed empirical research sug-
gested that psychosocial treatment should be tailored to pa-
tients’ individuality and context144,145. Further research
should address the need for more precise treatments,
whereby evidence-based interventions can be personalized
to the individual characteristics of people misusing sub-
stances146. In the absence of reliable predictors of response
to different therapies, a better understanding of the under-
pinnings of psychosocial interventions in stimulant use dis-
orders will aid clinical judgment. 
Likewise, interventions for stimulant use disorders are di-
verse, but they generally involve a therapeutic relationship
between patient and therapist, with CM being the only ex-
ception. Considering all the theoretical and practical differ-
ences between psychosocial interventions, the “equivalence
paradox” argues that a shared therapeutic alliance is essen-
tial for successful treatment of mental illness147, a concept
which could hold true for stimulant use disorders. 
Some studies tested a range of combined treatments and
there is evidence that the combination of diverse approach-
es, especially CM with other interventions, is feasible and
leads to better outcomes in patients with several needs148.
This review provide clarity around the similarities and dif-
ferences between psychosocial interventions and therefore
represent a useful framework for clinicians to conceive com-
bined interventions that are clinically meaningful and likely
to provide additive or synergistic effects.
This review has several limitations. We only included psy-
chosocial interventions investigated in randomized con-
trolled trials leading to published articles, so it is conceivable
that some treatments are not reported because no random-
ized controlled trials assessed them or, if so, they were not
published. Although the search algorithm allowed a method-
ical analysis of the literature, the presentation of findings is
narrative and we did not quantitatively analyze clinical out-
come measures such as acceptability and efficacy, for which
we refer to other studies15. 
In conclusion, our study shows that numerous psychoso-
cial interventions are available for the treatment of stimulant
use disorders. Different interventions should be offered, ei-
ther alone or in combination, according to patients’ circum-
stances and needs. Additional evidence from primary and
secondary research is required to characterize profile of dif-
ferential response to treatment and compare psychosocial in-
terventions, therefore providing useful guidance for clini-
cians and patients.
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Take home messages
• Psychosocial interventions are a heterogeneous group of
treatments with the best evidence-base for stimulant use
disorders, but the indications for each intervention are
unclear.
• Contingency management, cognitive behavioral interven-
tions, community reinforcement approach, 12-step pro-
gram, meditation-based interventions and physical exer-
cise, supportive expressive psychodynamic therapy, inter-
personal psychotherapy, family therapy, motivational in-
terviewing, and drug counseling have been assessed in
randomized controlled trials for the treatment of stimu-
lant use disorders.
• A range of theoretical and practical factors distinguishes
between interventions and different treatments are
preferable in specific clinical groups according to pa-
tients’ individual characteristics.
• An effective therapeutic alliance is a commonly shared
feature potentially explaining why different interventions
are equally beneficial within the same clinical contexts.
• Interventions can be combined to achieve better results
in complex patients with multiple needs.
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